1072 related articles for article (PubMed ID: 16288365)
1. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
[TBL] [Abstract][Full Text] [Related]
2. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
3. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics.
Helms DJ; Mosure DJ; Metcalf CA; Douglas JM; Malotte CK; Paul SM; Peterman TA
Sex Transm Dis; 2008 May; 35(5):484-8. PubMed ID: 18360314
[TBL] [Abstract][Full Text] [Related]
5. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea.
Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P
Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203
[TBL] [Abstract][Full Text] [Related]
6. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.
Van Der Pol B; Kwok C; Pierre-Louis B; Rinaldi A; Salata RA; Chen PL; van de Wijgert J; Mmiro F; Mugerwa R; Chipato T; Morrison CS
J Infect Dis; 2008 Feb; 197(4):548-54. PubMed ID: 18275275
[TBL] [Abstract][Full Text] [Related]
7. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.
Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM
Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria.
Konje JC; Otolorin EO; Ogunniyi JO; Obisesan KA; Ladipo OA
Afr J Med Med Sci; 1991 Mar; 20(1):29-34. PubMed ID: 1905467
[TBL] [Abstract][Full Text] [Related]
9. Trichomoniasis and its treatment.
Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
[TBL] [Abstract][Full Text] [Related]
10. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.
Klebanoff MA; Carey JC; Hauth JC; Hillier SL; Nugent RP; Thom EA; Ernest JM; Heine RP; Wapner RJ; Trout W; Moawad A; Leveno KJ; Miodovnik M; Sibai BM; Van Dorsten JP; Dombrowski MP; O'Sullivan MJ; Varner M; Langer O; McNellis D; Roberts JM;
N Engl J Med; 2001 Aug; 345(7):487-93. PubMed ID: 11519502
[TBL] [Abstract][Full Text] [Related]
11. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.
Roth AM; Williams JA; Ly R; Curd K; Brooks D; Arno J; Van Der Pol B
Sex Transm Dis; 2011 May; 38(5):398-400. PubMed ID: 21217417
[TBL] [Abstract][Full Text] [Related]
12. Premature with trichomoniasis: report of one case.
Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ
Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336
[TBL] [Abstract][Full Text] [Related]
13. A Community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania.
Klinger EV; Kapiga SH; Sam NE; Aboud S; Chen CY; Ballard RC; Larsen U
Sex Transm Dis; 2006 Dec; 33(12):712-8. PubMed ID: 16755271
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
[TBL] [Abstract][Full Text] [Related]
15. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Trichomonas vaginalis infection in women attending a major gynaecological hospital in Greece: a cross-sectional study.
Piperaki ET; Theodora M; Mendris M; Barbitsa L; Pitiriga V; Antsaklis A; Tsakris A
J Clin Pathol; 2010 Mar; 63(3):249-53. PubMed ID: 20203225
[TBL] [Abstract][Full Text] [Related]
17. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
Mammen-Tobin A; Wilson JD
Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
[TBL] [Abstract][Full Text] [Related]
18. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology.
Cherpes TL; Wiesenfeld HC; Melan MA; Kant JA; Cosentino LA; Meyn LA; Hillier SL
Sex Transm Dis; 2006 Dec; 33(12):747-52. PubMed ID: 16691155
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and incidence of Trichomonas vaginalis infections in women participating in a clinical trial in Durban, South Africa.
Naidoo S; Wand H
Sex Transm Infect; 2013 Sep; 89(6):519-22. PubMed ID: 23605853
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
